FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1340109008: Product containing only bimekizumab in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5372935011 Product containing only bimekizumab in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5372936012 Bimekizumab only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5372935011 Product containing only bimekizumab in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5372936012 Bimekizumab only product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing only bimekizumab in parenteral dose form (medicinal product form) Is a Product containing only bimekizumab (medicinal product) true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only bimekizumab in parenteral dose form (medicinal product form) Is a Bimekizumab-containing product in parenteral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only bimekizumab in parenteral dose form (medicinal product form) Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only bimekizumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bimekizumab true Inferred relationship Existential restriction modifier (core metadata concept) 1
Inbound Relationships Type Active Source Characteristic Refinability Group
Bimekizumab 160 mg/mL solution for injection Is a True Product containing only bimekizumab in parenteral dose form (medicinal product form) Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start